Characteristic expression of major histocompatibility complex and immune privilege genes in human pluripotent stem cells and their derivatives

Cell Transplantation

Volumn 24, Issue 5, 2015, Pages 845-864

  Chen, Hsin Fu ^a,b   Yu, Chun Ying ^c   Chen, Mei Jou ^a   Chou, Shiu Huey ^d   Chiang, Ming Shan ^a   Chou, Wen Hsi ^a   Ko, Bor Sheng ^e,f   Huang, Hsiang Po ^b   Kuo, Hung Chih ^c   Ho, Hong Nerng ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c INSTITUTE OF CELLULAR AND ORGANISMIC BIOLOGY   (Taiwan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^f NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Embryonic stem cells; Immune privilege; Immunogenicity; Induced pluripotent stem cells; Major histocompatibility complex (MHC); Pluripotent stem cells

Indexed keywords

ARGINASE; ARGINASE 2; B7 ANTIGEN; BETA 2 MICROGLOBULIN; CD59 ANTIGEN; CD86 ANTIGEN; FAS LIGAND; GAMMA INTERFERON; GLYCOPROTEIN P 15095; HEME OXYGENASE 1; HLA ANTIGEN; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; HLA E ANTIGEN; INDOLE; INDOLE 1; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR; PROOPIOMELANOCORTIN; TRANSCRIPTION FACTOR GATA 3; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; DIFFERENTIATION ANTIGEN;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINE; CONTROLLED STUDY; CYTOLYSIS; EMBRYONIC STEM CELL; FLOW CYTOMETRY; FLUORESCENCE; GENE EXPRESSION; HLA TYPING; HUMAN; HUMAN CELL; IMMUNOGENICITY; IN VITRO STUDY; LIVER CELL; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE REACTION; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOMATIC CELL; STEM CELL; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; GENE EXPRESSION REGULATION; IMMUNOLOGY; METABOLISM;

ANTIGENS, DIFFERENTIATION; CELL DIFFERENTIATION; CELLS, CULTURED; GENE EXPRESSION REGULATION; HLA ANTIGENS; HUMANS; INDUCED PLURIPOTENT STEM CELLS;

EID: 84928954783     PISSN: 09636897     EISSN: 15553892     Source Type: Journal    
DOI: 10.3727/096368913X674639     Document Type: Article

References (41)

1. Abdullah, Z.; Saric, T.; Kashkar, H.; Baschuk, N.; Yazdanpanah, B.; Fleischmann, B. K.; Hescheler, J.; Kronke, M.; Utermohlen, O. Serpin-6 expression protects embryonic stem cells from lysis by antigen-specific CTL. J. Immunol. 178(6):3390–3399; 2007.
2. Biassoni, R.; Cantoni, C.; Pende, D.; Sivori, S.; Parolini, S.; Vitale, M.; Bottino, C.; Moretta, A. Human natural killer cell receptors and co-receptors. Immunol. Rev. 181:203–214; 2001.
3. Bonde, S.; Chan, K. M.; Zavazava, N. ES-cell derived hematopoietic cells induce transplantation tolerance. PLoS ONE 3(9):e3212; 2008.
4. Bonde, S.; Zavazava, N. Immunogenicity and engraftment of mouse embryonic stem cells in allogeneic recipients. Stem Cells 24(10):2192–2201; 2006.
5. Boyd, A. S.; Wood, K. J. Variation in MHC expression between undifferentiated mouse ES cells and ES cell-derived insulin-producing cell clusters. Transplantation 87(9):1300–1304; 2009.
6. Bradley, J. A.; Bolton, E. M.; Pedersen, R. A. Stem cell medicine encounters the immune system. Nat. Rev. Immunol. 2(11):859–871; 2002.
7. Bronte, V.; Zanovello, P. Regulation of immune responses by L-arginine metabolism. Nat. Rev. Immunol. 5(8): 641–654; 2005.
8. Chen, H. F.; Chuang, C. Y.; Shieh, Y. K.; Chang, H. W.; Ho, H. N.; Kuo, H. C. Novel autogenic feeders derived from human embryonic stem cells (hESCs) support an undifferentiated status of hESCs in xeno-free culture conditions. Hum. Reprod. 24(5):1114–1125; 2009.
9. Chen, H. F.; Kuo, H. C.; Chen, W.; Wu, F. C.; Yang, Y. S.; Ho, H. N. A reduced oxygen tension (5%) is not beneficial for maintaining human embryonic stem cells in the undifferentiated state with short splitting intervals. Hum. Reprod. 24(1):71–80; 2009.
10. Chen, H. F.; Kuo, H. C.; Chien, C. L.; Shun, C. T.; Yao, Y. L.; Ip, P. L.; Chuang, C. Y.; Wang, C. C.; Yang, Y. S.; Ho, H. N. Derivation, characterization and differentiation of human embryonic stem cells: Comparing serum-containing versus serum-free media and evidence of germ cell differentiation. Hum. Reprod. 22(2):567–577; 2007.
11. Chen, H. F.; Kuo, H. C.; Lin, S. P.; Chien, C. L.; Chiang, M. S.; Ho, H. N. Hypoxic culture maintains self-renewal and enhances embryoid body formation of human embryonic stem cells. Tissue Eng. Part A 16(9):2901–2913; 2010.
12. Chen, H. F.; Lin, C. Y.; Chao, K. H.; Wu, M. Y.; Yang, Y. S.; Ho, H. N. Defective production of interleukin-11 by decidua and chorionic villi in human anembryonic pregnancy. J. Clin. Endocrinol. Metab. 87(5):2320–2328; 2002.
13. Chidgey, A. P.; Layton, D.; Trounson, A.; Boyd, R. L. Tolerance strategies for stem-cell-based therapies. Nature 453 (7193):330–337; 2008.
14. Deuse, T.; Stubbendorff, M.; Tang-Quan, K.; Phillips, N.; Kay, M. A.; Eiermann, T.; Phan, T. T.; Volk, H. D.; Reichenspurner, H.; Robbins, R. C.; Schrepfer, S. Immuno-genicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells. Cell Transplant. 20(5): 655–667; 2010.
15. Draper, J. S.; Andrews, P. W. Embryonic stem cells: Advances toward potential therapeutic use. Curr. Opin. Obstet. Gynecol. 14(3):309–315; 2002.
16. Draper, J. S.; Pigott, C.; Thomson, J. A.; Andrews, P. W. Surface antigens of human embryonic stem cells: Changes upon differentiation in culture. J. Anat. 200(Pt 3):249–258; 2002.
17. Dressel, R.; Schindehutte, J.; Kuhlmann, T.; Elsner, L.; Novota, P.; Baier, P. C.; Schillert, A.; Bickeboller, H.; Herrmann, T.; Trenkwalder, C.; Paulus, W.; Mansouril, A. The tumorigenicity of mouse embryonic stem cells and in vitro differentiated neuronal cells is controlled by the recipients’ immune response. PLoS ONE 3(7):e2622; 2008.
18. Drukker, M. Immunogenicity of embryonic stem cells and their progeny. Methods Enzymol. 420:391–409; 2006.
19. Drukker, M.; Benvenisty, N. The immunogenicity of human embryonic stem-derived cells. Trends Biotechnol. 22(3): 136–141; 2004.
20. Drukker, M.; Katchman, H.; Katz, G.; Even-Tov Friedman, S.; Shezen, E.; Hornstein, E.; Mandelboim, O.; Reisner, Y.; Benvenisty, N. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 24(2):221–229; 2006.
21. Drukker, M.; Katz, G.; Urbach, A.; Schuldiner, M.; Markel, G.; Itskovitz-Eldor, J.; Reubinoff, B.; Mandelboim, O.; Benvenisty, N. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc. Natl. Acad. Sci. USA 99(15):9864–9869; 2002.
22. Ezashi, T.; Das, P.; Roberts, R. M. Low O2 tensions and the prevention of differentiation of hES cells. Proc. Natl. Acad. Sci. USA 102(13):4783–4788; 2005.
23. Fairchild, P. J. The challenge of immunogenicity in the quest for induced pluripotency. Nat. Rev. Immunol. 10(12): 868–875; 2010.
24. Huang, H. P.; Yu, C. Y.; Chen, H. F.; Chen, P. H.; Chuang, C. Y.; Lin, S. J.; Huang, S. T.; Chan, W. H.; Ueng, T. H.; Ho, H. N.; Kuo, H. C. Factors from human embryonic stem cell-derived fibroblast-like cells promote topology-dependent hepatic differentiation in primate embryonic and induced pluripotent stem cells. J. Biol. Chem. 285(43):33510–33519; 2010.
25. Juszczynski, P.; Ouyang, J.; Monti, S.; Rodig, S. J.; Takeyama, K.; Abramson, J.; Chen, W.; Kutok, J. L.; Rabinovich, G. A.; Shipp, M. A. The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma. Proc. Natl. Acad. Sci. USA 104(32):13134–13139; 2007.
26. Li, L.; Baroja, M. L.; Majumdar, A.; Chadwick, K.; Rouleau, A.; Gallacher, L.; Ferber, I.; Lebkowski, J.; Martin, T.; Madrenas, J.; Bhatia, M. Human embryonic stem cells possess immune-privileged properties. Stem Cells 22(4):448–456; 2004.
27. Mandelboim, O.; Lieberman, N.; Lev, M.; Paul, L.; Arnon, T. I.; Bushkin, Y.; Davis, D. M.; Strominger, J. L.; Yewdell, J. W.; Porgador, A. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409(6823):1055–1060; 2001.
28. Mellor, A. L.; Munn, D. H. Tryptophan catabolism and regulation of adaptive immunity. J. Immunol. 170(12):5809–5813; 2003.
29. Robertson, N. J.; Brook, F. A.; Gardner, R. L.; Cobbold, S. P.; Waldmann, H.; Fairchild, P. J. Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance. Proc. Natl. Acad. Sci. USA 104(52):20920–20925; 2007.
30. Saric, T.; Frenzel, L. P.; Hescheler, J. Immunological barriers to embryonic stem cell-derived therapies. Cells Tissues Organs 188(1–2):78–90; 2008.
31. Streilein, J. W. Ocular immune privilege: Therapeutic opportunities from an experiment of nature. Nat. Rev. Immunol. 3(11):879–889; 2003.
32. Swijnenburg, R. J.; Tanaka, M.; Vogel, H.; Baker, J.; Kofidis, T.; Gunawan, F.; Lebl, D. R.; Caffarelli, A. D.; de Bruin, J. L.; Fedoseyeva, E. V.; Robbins, R. C. Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation 112(9 Suppl):I166–172; 2005.
33. Tabayoyong, W. B.; Salas, J. G.; Bonde, S.; Zavazava, N. HOXB4-transduced embryonic stem cell-derived Lin-c-kit+ and Lin-Sca-1+ hematopoietic progenitors express H60 and are targeted by NK cells. J. Immunol. 183(9):5449–5457; 2009.
34. Taylor, C. J.; Bolton, E. M.; Pocock, S.; Sharples, L. D.; Pedersen, R. A.; Bradley, J. A. Banking on human embryonic stem cells: Estimating the number of donor cell lines needed for HLA matching. Lancet 366(9502):2019–2025; 2005.
35. Thomson, J. A.; Itskovitz-Eldor, J.; Shapiro, S. S.; Waknitz, M. A.; Swiergiel, J. J.; Marshall, V. S.; Jones, J. M. Embryonic stem cell lines derived from human blastocysts. Science 282(5391):1145–1147; 1998.
36. Walker, P. R.; Saas, P.; Dietrich, P. Y. Role of Fas ligand (CD95L) in immune escape: The tumor cell strikes back. J. Immunol. 158(10):4521–4524; 1997.
37. Wilbanks, G. A.; Mammolenti, M.; Streilein, J. W. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta. Eur. J. Immunol. 22(1):165–173; 1992.
38. Wu, D. C.; Boyd, A. S.; Wood, K. J. Embryonic stem cells and their differentiated derivatives have a fragile immune privilege but still represent novel targets of immune attack. Stem Cells 26(8):1939–1950; 2008.
39. Yagi, H.; Soto-Gutierrez, A.; Parekkadan, B.; Kitagawa, Y.; Tompkins, R. G.; Kobayashi, N.; Yarmush, M. L. Mesen-chymal stem cells: Mechanisms of immunomodulation and homing. Cell Transplant. 19(6):667–679; 2010.
40. Yamanaka, S. A fresh look at iPS cells. Cell 137(1): 13–17; 2009.
41. Zhao, T.; Zhang, Z. N.; Rong, Z.; Xu, Y. Immunogenicity of induced pluripotent stem cells. Nature 474(7350): 212–215; 2011.